CLYM · Categories · Form 4

CLYM - SEC Form 4 insider transactions

Climb Bio Inc. (CLYM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CLYM

• 23h
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 23h
  SEC Form 4 filed by Director Levin Andrew David

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 23h
  SEC Form 4 filed by Director Drapkin Kimberlee C

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 23h
  SEC Form 4 filed by Director Williams Douglas E

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 23h
  SEC Form 4 filed by Director Cumbo Alexander

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 23h
  SEC Form 4 filed by Director Thomas Stephen Basil

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 23h
  SEC Form 4 filed by Director Dunn Judith

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 40d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 102d
  Director Thomas Stephen Basil sold $350,253 worth of shares (50,000 units at $7.01), decreasing direct ownership by 24% to 154,657 units (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 112d
  Director Thomas Stephen Basil sold $529,129 worth of shares (100,000 units at $5.29), decreasing direct ownership by 33% to 204,657 units (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 152d
  SEC Form 4 filed by Chief Business Officer Wilson Perrin Megan

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 152d
  SEC Form 4 filed by President and CEO Brennan Aoife

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 152d
  SEC Form 4 filed by Senior Vice President, Finance Driscoll Cindy

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 152d
  SEC Form 4 filed by Chief Financial Officer Altschuller Susan

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 251d
  SEC Form 4 filed by Chief Financial Officer Altschuller Susan

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 302d
  Director Thomas Stephen Basil was granted 100,375 shares, increasing direct ownership by 49% to 304,657 units (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 343d
  President and CEO Brennan Aoife converted options into 68,750 shares and sold $25,154 worth of shares (20,618 units at $1.22) (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 343d
  Director Thomas Stephen Basil converted options into 25,094 shares, increasing direct ownership by 14% to 204,282 units (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 354d
  SEC Form 4 filed by Senior Vice President, Finance Driscoll Cindy

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 354d
  SVP, Finance & CAO Pimblett Emily converted options into 5,000 shares and sold $1,540 worth of shares (1,242 units at $1.24), increasing direct ownership by 25% to 18,888 units (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 369d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 369d
  SEC Form 4 filed by Director Drapkin Kimberlee C

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 369d
  SEC Form 4 filed by Director Cumbo Alexander

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 369d
  SEC Form 4 filed by Director Dunn Judith

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 369d
  SEC Form 4 filed by Director Williams Douglas E

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 369d
  SEC Form 4 filed by Director Thomas Stephen Basil

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 369d
  SEC Form 4 filed by Director Levin Andrew David

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 434d
  SEC Form 4 filed by Director Williams Douglas E

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 434d
  SEC Form 4 filed by Director Drapkin Kimberlee C

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 434d
  SEC Form 4 filed by Director Cumbo Alexander

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 439d
  Director Thomas Stephen Basil converted options into 25,093 shares, increasing direct ownership by 16% to 179,188 units (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 446d
  SVP, Finance & CAO Pimblett Emily converted options into 5,000 shares and sold $1,571 worth of shares (1,199 units at $1.31), increasing direct ownership by 34% to 15,130 units (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 510d
  SEC Form 4 filed by Chief Operating Officer Kaplan Brett

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 510d
  SEC Form 4 filed by President and CEO Brennan Aoife

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 510d
  SEC Form 4 filed by SVP, Finance and CAO Pimblett Emily

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 522d
  Director Thomas Stephen Basil converted options into 50,188 shares, increasing direct ownership by 48% to 154,095 units (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 536d
  CHIEF ACCOUNTING OFFICER Pimblett Emily converted options into 5,000 shares and sold $2,495 worth of shares (1,235 units at $2.02), increasing direct ownership by 50% to 11,329 units (SEC Form 4)

  4 - Climb Bio, Inc. (0001768446) (Issuer)
• 573d
  SEC Form 4 filed by Director Williams Douglas E

  4 - Climb Bio, Inc. (0001768446) (Issuer)

Other CLYM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends